InvestorsHub Logo
Followers 28
Posts 344
Boards Moderated 0
Alias Born 07/23/2013

Re: govorchin post# 58045

Friday, 04/04/2014 1:22:21 PM

Friday, April 04, 2014 1:22:21 PM

Post# of 403599
ly2835219 is a study of the drug Fulvestrant, a synthetic estrogen receptor antagonist. It involves a few different types of solid tumor cancers. Dr. Shapiro is the lead investigator. Here is the link:

http://www.dana-farber.org/research/clinical-trials/clinical-trial.aspx?tid=2386

Edit: Shapiro is the site investigator at DF.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News